Clinical Suitability of Artificial Intelligence ProgramsNear Infrared SpectroscopyCardiac Surgery
Investigational drug(s) / intervention(s)
CHATGPT GROUPGEMINI GROUPCOPILOT GROUPCLINICIAN GROUP
CHATGPT GROUP: CHATGPT responses
GEMINI GROUP: GEMINI responses
COPILOT GROUP: COPILOT responses
CLINICIAN GROUP: CLINICIAN responses
Study summary
The aim of the present study is to test the accuracy and reliability of AI tools in this regard by interpreting NIRS, which we routinely use for monitoring cerebral perfusion in cardiovascular surgery, with AI tools and comparing this interpretation with the interpretations of two clinicians.
Eligibility
Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria:
* open cardiac surgery
* elective open heart surgery
* aged 18-65
* ASA score I-III
* BMI \<30 kg/m2
Exclusion Criteria:
* past ischemic event
* carotid arter stenosis
* BMI \>30 kg/m2
* serious liver or kidney disease
* ASA 4 ve more
* anatomical abnormality at probe site
* history of mental or neurological disease,
* history of previous intracranial aneurysm or intracranial tumor surgery
* history of moderate or severe pulmonary disease,
* emergency surgery
Primary outcome measure(s)
Clinical Experience — 12 hour The proximity of AI programs to the clinical experience
Trial sites (1)
Facility
City
Region
Status
Antalya Training and Researching hospital
Antalya
Muratpaşa
More Antalya Health Sciences University trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.